University of Oklahoma: Atrial Fibrillation trials
The registry lists 12 Atrial Fibrillation studies with University of Oklahoma as lead sponsor. 4 are open to participants now and 4 have results posted.
Early Phase 1 1Phase 1 1Phase 3 2No phase 8(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Dapagliflozin in Patients With Atrial Fibrillation (DAPA-AF)RecruitingNCT05174052Phase 3
- Biomarker-Guided Optimization of Transcutaneous Vagal Stimulation for Atrial (BiG tVNS-AF)RecruitingNCT05172765Not applicable
- Synaptic Plasticity in the Epicardial Ganglionated PlexiRecruitingNCT05034419Phase 1
- The Effect of Different Low-Level Tragus Stimulation Parameters On Autonomic Nervous System FunctionRecruitingNCT04682704Not applicable
- Transcutaneous Electrical Vagus Nerve Stimulation to Suppress Atrial FibrillationCompletedNCT02548754Not applicableResults posted
- Ranolazine for the Prevention of Atrial Fibrillation After Electrical CardioversionTerminatedNCT01349491Phase 3Results posted
- Early Detection and Treatment of Esophageal Injury After Catheter Ablation for Atrial FibrillationCompletedNCT00584922Results posted
- Navi-Star Thermo-Cool Catheter For Ablation of Atrial FibrillationCompletedNCT00584415Not applicableResults posted
- SmartWatch ECG Evaluation Trial IWithdrawnNCT05942274Not applicable
- Dual Versus Single Shock for Cardioversion of Atrial FibrillationTerminatedNCT03943693Early Phase 1
- Screening for Atrial Fibrillation in Native AmeRicans Using iPhone ECGCompletedNCT03740477Not applicable
- Low-Level EMF Stimulation for Paroxysmal Atrial FibrillationCompletedNCT03593486Not applicable